Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Intoleran is a specialized healthcare company focused on the development and manufacturing of digestive enzyme supplements to address various food intolerances. Based in the Netherlands, the company provides targeted solutions for conditions such as lactose, fructose, and histamine intolerance, as well as difficulties digesting complex carbohydrates. Their product line, which includes specialized formulations like Quatrase and Fibractase, is produced in-house under strict quality standards and often carries the Monash University Low FODMAP certification. Intoleran aims to improve the quality of life for individuals with digestive sensitivities by offering high-potency, scientifically-supported enzyme formulations. The company operates globally, distributing its products to consumers and healthcare professionals seeking effective management strategies for Irritable Bowel Syndrome (IBS) and related digestive disorders.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intoleran.